How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
IV Fluid Monitoring Device Market
- By Product Type: Electronic IV Fluid Monitors, Mechanical IV Fluid Monitors, Smart IV Infusion Pumps, Gravity-Based IV Flow Regulators, IV Fluid Level Sensors
- By End User: Hospitals, Ambulatory Surgical Centers, Home Healthcare Settings, Clinics, Long-Term Care Facilities
- By Technology: Optical Sensors, Ultrasonic Sensors, Capacitive Sensors, Pressure-Based Sensors, Flow Rate Sensors
- By Application: Intravenous Therapy, Blood Transfusion Monitoring, Chemotherapy Administration, Parenteral Nutrition, Anesthesia Delivery
- By Product Feature: Real-Time Fluid Volume Monitoring, Alarm Systems for Flow Interruption, Wireless Connectivity, Battery-Powered Devices, Data Logging and Analytics
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Electronic IV Fluid Monitors leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 17 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 310 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.186 →
- 12 Company Profiles 17 players: SWOT & benchmarking p.194 →
Full report · locked preview
Everything inside the IV Fluid Monitoring Device Market report
A complete, evidence-based study - 12 chapters and 130 sections covering market size, segmentation across 5 axes, regional analysis and 17 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
End User 5
Technology 5
Application 5
Product Feature 5
Companies profiled
Baxter International Inc.
B. Braun Melsungen AG
Smiths Medical (a division of ICU Medical
Inc.)
Fresenius Kabi AG
Terumo Corporation
Hospira (a Pfizer company)
Nipro Corporation
Moog Inc.
ICU Medical Inc.
Medtronic plc
CareFusion Corporation (a BD company)
+5 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
17 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Baxter International Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →B. Braun Melsungen AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Smiths Medical (a division of ICU Medical
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Inc.)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Fresenius Kabi AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Terumo Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Hospira (a Pfizer company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Nipro Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Moog Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →ICU Medical Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Medtronic plc
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →CareFusion Corporation (a BD company)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Nihon Kohden Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.227 →InfuSystem Holdings Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Becton
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Dickinson and Company (BD)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Stryker Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.250 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$7,018M by 2033 · 5.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Electronic IV Fluid Monitors36.8
- Mechanical IV Fluid Monitors22.1
- Smart IV Infusion Pumps8.6
- Gravity-Based IV Flow Regulators20.6
- IV Fluid Level Sensors11.9
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,500M → $2,514M · 6.7%
Europe$1,046M → $1,617M · 5.6%
Asia Pacific$954.7M → $1,402M · 4.9%
Latin America$591.0M → $832.2M · 4.4%
Middle East and Africa$454.6M → $668.8M · 4.9%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →5.542026
5.542027
5.552028
5.572029
5.582030
5.582031
5.592032
5.622033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Baxter International Inc.29.0
- B. Braun Melsungen AG11.0
- Smiths Medical (a division of ICU Medical5.7
- Inc.)11.7
- Fresenius Kabi AG7.2
- Terumo Corporation7.5
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type33.5%
End User20.7%
Technology11.6%
Application13.6%
Product Feature20.6%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America35.7
- Europe23.0
- Asia Pacific19.9
- Latin America11.8
- Middle East and Africa9.5
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Baxter International Inc. | 87 | 78 | 94 | 74 | 80 | 99 | 85 |
| B. Braun Melsungen AG | 75 | 92 | 90 | 90 | 73 | 69 | 82 |
| Smiths Medical (a division of ICU Medical | 69 | 63 | 80 | 76 | 79 | 74 | 74 |
| Inc.) | 61 | 67 | 80 | 70 | 65 | 60 | 67 |
| Fresenius Kabi AG | 56 | 54 | 71 | 74 | 60 | 73 | 65 |
| Terumo Corporation | 54 | 51 | 50 | 49 | 67 | 57 | 55 |
| Hospira (a Pfizer company) | 51 | 41 | 63 | 65 | 51 | 55 | 54 |
| Nipro Corporation | 45 | 41 | 60 | 35 | 42 | 36 | 43 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Baxter International Inc.
- B. Braun Melsungen AG
- Smiths Medical (a division of ICU Medical
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Baxter International Inc. | ◐ | ◐ | ✓ | ✓ | ◐ | ✓ |
| B. Braun Melsungen AG | ✓ | ◐ | ◐ | ✓ | ◐ | ◐ |
| Smiths Medical (a division of ICU Medical | ✓ | ◐ | ✓ | ✓ | ◐ | ◐ |
| Inc.) | − | ◐ | ◐ | − | ◐ | ◐ |
| Fresenius Kabi AG | − | − | ✓ | ◐ | − | ◐ |
| Terumo Corporation | − | − | − | − | − | ◐ |
| Hospira (a Pfizer company) | ◐ | − | − | ◐ | − | ◐ |
| Nipro Corporation | − | ◐ | ◐ | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Baxter International Inc.85
2B. Braun Melsungen AG82
3Smiths Medical (a division of ICU Medical74
4Inc.)67
5Fresenius Kabi AG65
6Terumo Corporation55
7Hospira (a Pfizer company)54
8Nipro Corporation43
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Baxter International Inc.B. Braun Melsungen AG
Challenger2
Strong scale, closing on the leaders.
Smiths Medical (a division of ICU MedicalInc.)
Contender1
Focused players with pockets of strength.
Fresenius Kabi AG
Niche3
Specialists in a single segment or region.
Terumo CorporationHospira (a Pfizer company)Nipro Corporation
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across IV Fluid Monitoring Device Market — a $186M beachhead inside a $2.53B market.
Beachhead (SOM)$186Mobtainable near-term
Serviceable (SAM)$1.02Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Electronic IV Fluid Monitors
Best fit — highest urgency & budget in Product Type.
Economic buyer76 fit
Mechanical IV Fluid Monitors
Strong fit — clear ROI and a fast path to value.
End user68 fit
Smart IV Infusion Pumps
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End User & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Technology
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel28%
Digital / self-serve17%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win IV Fluid Monitoring Device Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified39%
Sales qualified22%
Evaluation12%
Closed-won8%
$12.1KCAC
$42KLTV
3.5:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
IV Fluid Monitoring Device Market is a durable-growth opportunity — $6.25B by 2033, compounding at 7.3%.
TAM · 2025$3.56Btoday
TAM · 2033$6.25Bforecast
CAGR7.3%2027–2033
Cumulative$43.1Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.25BTotal addressable market
SAM$2.14BServiceable available market
SOM$377MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.3% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
17+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.25BLarge & growingTAM by 2033 at 7.3% CAGR
$2.14BServiceable nowreachable with today’s model
$377MBeachhead winobtainable near-term share
17+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.87BBear4.7% CAGR
$6.25BBase7.3% CAGR
$8.00BBull9.6% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End User optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
IV Fluid Monitoring Device Market — a $679M market by 2033. Plan: grow share from 11.3% to 17.4%.
Market size · 2033$679Mtotal addressable
Market CAGR5.6%2027–2033
Target share17.4%from 11.3% today
Revenue ambition$118Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 11.3% | 17.4% | At risk |
| Revenue | $73M | $118M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 29.0% | 40.9% | At risk |
| Customer retention | 84.1% | 94.7% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End User capability
A defensible second engine — invest in End User to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End User
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $13M capacity & capability investment
- Greenlight bolt-on M&A in End User
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskBehind
- Regulatory / policy changeAt risk
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the IV Fluid Monitoring Device Market conversation — a $6.37B market you can size, segment and defend in minutes.
Market size · 2033$6.37Btotal opportunity
Growth3.3%CAGR to 2033
Addressable buyers1,074+accounts in scope
Typical ROI5.7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.7×return on cost, year one
< 3 mopayback period
$100K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
17+players profiled in this market
Coverage includes
Baxter International Inc.B. Braun Melsungen AGSmiths Medical (a division of ICU MedicalInc.)Fresenius Kabi AGTerumo CorporationHospira (a Pfizer company)Nipro Corporation+9 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your IV Fluid Monitoring Device Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
IV Fluid Monitoring Device Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →IV Fluid Bags Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportIVF Gamete Buffer Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportIVF Follicle Flush Buffer Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportIVF Fertilization Medium Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportIVF Culture Oils Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportIVF Culture Media Market
Market size, share, segmentation and regional forecast.
$897M market · 2025 base year
View reportIVF Culture Dishes Market
Market size, share, segmentation and regional forecast.
$793M market · 2025 base year
View reportIVF Central Hole Petri Dishes Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportIVF Blastocyst Medium Market
Market size, share, segmentation and regional forecast.
$990M market · 2025 base year
View reportIVF and ART Incubators Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportIV Extension Set Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportIvermectin Medication Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.